RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 15 - per page Next page
Order by
The China Post Article on TaiGen Biotech
TaiGen opens new biotech facility in Taipei's Neihu area More
TaiGen and Chang Gung Memorial Hospital Signed Agreement
Gene Expressing Profiling of Tumor and Liver Disease Tissues More
MPM Leads Financing of TaiGen
MPM Leads Financing of TaiGen, a Taiwanese Biotech Company Founded with GPC Receptor Technology from Arena Pharmaceuticals More
New Ferring International Center opens for business
New state-of-the-art Ferring International Center opens in Ørestad City, Copenhagen More
AFP Kit from CanAg Diagnostics
CanAg AFP assay kit - tumor marker for cancer of the liver, testis or ovary More
ASTRAZENECA AND AVENTIS COLLABORATE ON CLINICAL TRIALS PROGRAM FOR IRESSA (ZD1839) IN COMBINATION WITH TAXOTERE. (DOCETAXEL) OR CAMPTO. (IRINOTECAN)
ASTRAZENECA AND AVENTIS COLLABORATE ON NEW TARGET FOR ANTI-CANCER TREATMENTS More
ARIMIDEX RECEIVES FDA PRIORITY REVIEW FOR EARLY BREAST CANCER INDICATION
The US FDA has granted a six-month Priority Review Status to the supplemental new drug application (sNDA) for Arimidex. More
Link Pharmaceuticals acquires the exclusive rights to market sell and distribute Gliadel® Wafer in the UK and Ireland
Link is granted exclusive rights to market, sell and distribute Guilford Pharmaceuticals proprietary brain cancer therapy, GLIADEL® Wafer, in the UK and Ireland. More
Amersham Health and Link Pharmaceuticals Sign Agreement to Promote METASTRON® for the Treatment of Metastatic Prostate Cancer in the UK
Link Pharmaceuticals to promote one of Amersham Health's most important therapy products, METASTRON® (strontium-89 chloride injection) for the treatment of pain from metastatic prostate cancer, in the UK. More
11th International Conference on Cancer Gene Therapy
Oncolytic Herpes simplex virus treatment, OncoVEX with chemotherapy, Herpes simplex virus as a vaccine delivery platform More
Displaying 1..10 of 15 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
ZIOPHARM Oncology Inc: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 40 pages - $495
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
Sonus Pharmaceuticals Inc: Premium Company Profile
Jan 2008 - 41 pages - $495
US Oncology, Inc. – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
US Oncology, Inc. - Strategy, SWOT and Corporate Finance Report
Mar 2011 - 33 pages - $125
Window Coverings/Treatments in Germany to 2015: Market Databook
Nov 2011 - 22 pages - $500
Window Coverings/Treatments in Italy to 2015: Market Databook
Nov 2011 - 22 pages - $500
Window Coverings/Treatments in France to 2015: Market Databook
Nov 2011 - 22 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us